![Paul M. Keane](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul M. Keane
Keine laufenden Positionen mehr
Karriereverlauf von Paul M. Keane
Ehemalige bekannte Positionen von Paul M. Keane
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Bayer, Inc.
![]() Bayer, Inc. Chemicals: AgriculturalProcess Industries Bayer, Inc. manufactures chemicals, healthcare, agricultural, and life science products. The company develops products that fight diseases, protects crops and animals, as well as develops materials. It was founded in 1936 and is headquartered in Toronto, Canada | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1989 | 01.01.1995 |
McMaster University | Corporate Officer/Principal | - | - |
University of Calgary | Corporate Officer/Principal | - | - |
YM BioSciences, Inc.
![]() YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1996 | - |
Statistik
International
Kanada | 4 |
Vereinigtes Königreich | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
YM BioSciences, Inc.
![]() YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
Bayer, Inc.
![]() Bayer, Inc. Chemicals: AgriculturalProcess Industries Bayer, Inc. manufactures chemicals, healthcare, agricultural, and life science products. The company develops products that fight diseases, protects crops and animals, as well as develops materials. It was founded in 1936 and is headquartered in Toronto, Canada | Process Industries |
- Börse
- Insiders
- Paul M. Keane
- Erfahrung